Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

BACKGROUND: Minimal change disease (MCD) has a high recurrence rate, but currently, no biomarker can predict its recurrence. To this end, this study aimed at identifying potential serum cytokines as valuable biomarkers for predicting the risk of MCD recurrence. MATERIALS AND METHODS: Raybiotech 440...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Mengqiu, Zhang, Jian, Su, Xinwan, Yao, Xi, Li, Heng, Cheng, Jun, Mao, Jianhua, Li, Xiayu, Chen, Jianghua, Lin, Weiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729255/
https://www.ncbi.nlm.nih.gov/pubmed/36507530
http://dx.doi.org/10.3389/fmed.2022.922193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729255/
https://www.ncbi.nlm.nih.gov/pubmed/36507530
http://dx.doi.org/10.3389/fmed.2022.922193

Ejemplares similares